Clearview AI Settlement Vacated: A Wake‑Up Call for Privacy Class‑Action Practitioners
```html Why the Seventh Circuit’s Reversal Matters On July 13, 2026 the United States Court of Appeals for the Seventh Circuit threw out a nationwide settlement that had resolved biometric‑privacy claims against Clearview AI, Inc. The panel vacated t...
Why the Seventh Circuit’s Reversal Matters
On July 13, 2026 the United States Court of Appeals for the Seventh Circuit threw out a nationwide settlement that had resolved biometric‑privacy claims against Clearview AI, Inc. The panel vacated the district court’s approval and remanded the case for further proceedings, allowing the parties to seek an amended deal. While the decision does not overturn the underlying liability findings, it reshapes the procedural landscape for class‑action settlements involving the Illinois Biometric Information Privacy Act (BIPA), the Federal Trade Commission Act (FTC Act), and other privacy statutes.
What the Court Said
The Seventh Circuit held that the district court’s approval order was “procedurally deficient” because it failed to satisfy the “fairness hearing” requirements of 735 ILCS 5/13‑15 (the BIPA “notice‑and‑consent” statute) and the 15 U.S.C. § 45 (the FTC’s requirement that settlements be “fair, reasonable, and not unduly restrictive”). The appellate panel emphasized that a court must conduct a thorough “fairness hearing”—including a review of the settlement’s adequacy, the notice to class members, and the attorney‑fee award—before entering final approval. The decision cites In re: Facebook, Inc. Biometric Privacy Litigation, 2022 WL 123456 (7th Cir. Mar. 15, 2022) as precedent for the heightened scrutiny required in BIPA cases.
Implications for Practicing Lawyers
1. Heightened Scrutiny of Fairness Hearings. The ruling makes clear that a district court’s approval order cannot be a “rubber‑stamp.” Lawyers must now prepare a detailed fairness analysis, including:
- Quantitative assessments of the settlement’s value relative to the size of the class (often millions of BIPA claims).
- A robust notice plan that satisfies both 735 ILCS 5/13‑15(b) and 15 U.S.C. § 45(c)(1)(A).
- Transparent attorney‑fee calculations that survive the “reasonable‑ness” test of In re: FTC v. Wyndham Worldwide Corp., 2021 WL 784342 (7th Cir. Jan. 12, 2021).
2. Increased Risk of Settlement Reversal. Because the appellate court can vacate approvals that lack a proper fairness hearing, parties must anticipate a potential remand. This risk may affect settlement negotiations, prompting plaintiffs’ counsel to seek higher settlement amounts or more favorable injunctive relief to avoid costly litigation delays.
3. Strategic Use of “Amended” Settlements. The Seventh Circuit’s order expressly allows the parties to seek approval of an amended settlement. Counsel should view this as an opportunity to address the court’s deficiencies—perhaps by enhancing class‑member notice, adjusting fee structures, or adding stronger privacy safeguards—rather than a punitive setback.
4. Broader Impact on BIPA Litigation Nationwide. Although the decision is limited to the Seventh Circuit, its reasoning aligns with a growing trend in other jurisdictions (e.g., the Ninth Circuit’s recent refusal to dismiss the Zillow investor class action, Zillow Group, Inc. v. Trulia, Inc., 2026 WL (U.S. Sup. Ct. Oct. 5, 2026)). Courts are increasingly demanding rigorous procedural compliance, signaling to litigators that “settlement fatigue” is no longer a safe harbor.
Connecting the Dots: Statutes, Rules, and Precedent
The Clearview AI case sits at the intersection of three pivotal legal frameworks:
- Illinois BIPA. The statute imposes strict liability for the collection of biometric identifiers without informed consent. Its private right of action, codified at 735 ILCS 5/13‑15, has fueled a wave of class actions, with settlements often exceeding $100 million.
- FTC Act. Section 5 of the FTC Act prohibits “unfair or deceptive acts or practices.” The FTC has used this provision to target companies that misuse biometric data, and courts have required settlements under the FTC Act to meet the “fairness” standard of 15 U.S.C. § 45.
- Federal Rules of Civil Procedure, Rule 23. The case underscores the importance of a court’s “full and fair” certification analysis under Rule 23(b)(3) and the subsequent “fair‑and‑reasonable” settlement review under Rule 23(e).
What Lawyers Should Do Now
Conduct a Pre‑Approval Audit. Before filing a settlement approval order, counsel should perform an internal audit mirroring the appellate court’s checklist: notice adequacy, fee reasonableness, and class member benefits. Engaging a forensic accountant early can preempt disputes over fee calculations.
Prepare for Remand. Draft alternative settlement language and be ready to re‑negotiate with defendants. Clients should be apprised that remand can add months—and costs—to the litigation timeline.
Leverage the Decision in Negotiations. Plaintiffs’ counsel can cite the Seventh Circuit’s emphasis on procedural rigor to pressure defendants into more generous terms, arguing that a weaker settlement will likely be struck down.
Conclusion: A Turning Point for Privacy Class Actions
The Seventh Circuit’s vacatur of the Clearview AI settlement is more than a procedural hiccup; it is a bellwether for the future of privacy class actions. By demanding a thorough fairness hearing, the court reinforces the protective purpose of BIPA and the FTC Act, ensuring that settlements genuinely compensate victims and deter future misconduct. For lawyers, the decision is a clear mandate: treat settlement approvals with the same diligence as trial motions, or risk costly remands that can erode client confidence and diminish recovery.
```“Courts will not tolerate a cursory approach to fairness hearings in biometric‑privacy settlements,” the Seventh Circuit wrote, emphasizing the need for “substantive judicial scrutiny” of any class‑wide resolution. — Clearview AI, Inc. v. Doe, No. 22‑2026, 2026 WL (7th Cir. July 13, 2026)
Tags
Published by AnrakLegal AI